(Q28263732)

object named as

Irvin M Modlin

0 references

Eric P. Krenning

object named as

Eric P Krenning

0 references

author name string

Kjell Oberg

0 references

Daniel C Chung

0 references

Robert T Jensen

0 references

Martyn Caplin

0 references

Greg A Kaltsas

0 references

Steven F Moss

0 references

Ola Nilsson

0 references

Ramon Salazar

0 references

Philippe Ruszniewski

0 references

Anders Sundin

Lancet Oncology Commission

0 references

language of work or name

English

0 references

publication date

January 2008

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

61-72

0 references

cites work

Neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Endocrine tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

The New Biology of Gastrointestinal Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Mutant neurogenin-3 in congenital malabsorptive diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

The functional characterization of normal and neoplastic human enterochromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Gastrin and the enterochromaffin-like cell: an acid update

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Genetics of neuroendocrine and carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Current status of gastrointestinal carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Chromosome 18 deletions are common events in classical midgut carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

The diagnosis and medical management of advanced neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Tumor markers in neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Prognosis of Carcinoid Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal o

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Practical markers used in the diagnosis of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Ultrasonography of the pancreas. 4. Contrast-enhanced imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Future horizons in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Superparamagnetic iron oxide nanoparticle probes for molecular imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Detection of small-bowel neuroendocrine tumors by video capsule endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Multiple carcinoid tumors of the ileum preoperatively diagnosed by enteroscopy with the double-balloon technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Surgery for primary pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Neuroendocrine tumors. Peptide receptor radionuclide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021

Survival From Malignant Digestive Endocrine Tumors in England and Wales: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970410-2

7 January 2021